1346242-32-7 ((αs)-n,n,α-三甲基-3-(4-硝基苯氧基)苯甲胺,(aS)-N,N,a-Trimethyl-3-(4-nitrophenoxy)benzenemethanamine)

(αs)-n,n,α-三甲基-3-(4-硝基苯氧基)苯甲胺;

(αS)-N,N,α-Trimethyl-3-(4-nitrophenoxy)benzenemethanamine;(1S)-N,N-dimethyl-1-[3-(4-nitrophenoxy)phenyl]ethanamine;(αS)-N,N,α-Trimethyl;UNII-HM1505E3C7;HM1505E3C7;1346242-32-7;Q27280001;(alphaS)-N,N,alpha-Trimethyl-3-(4-nitrophenoxy)benzenemethanamine;Rivastigmine tartrate impurity, ether impurity- [USP];BENZENEMETHANAMINE, N,N,.ALPHA.-TRIMETHYL-3-(4-NITROPHENOXY)-, (.ALPHA.S)-;Benzenemethanamine, N,N,alpha-trimethyl-3-(4-nitrophenoxy)-, (alphaS)-;(S)-N,N-Dimethyl-1-(3-(4-nitrophenoxy)phenyl)ethanamine;(S)-N,N-Dimethyl-1-[3-(4-nitrophenoxy)phenyl]ethanamine;Benzenemethanamine, N,N,a-trimethyl-3-(4-nitrophenoxy)-, (aS)-; (S)-N,N-Dimethyl-1-[3-(4-nitrophenoxy)phenyl]ethanamine;N,N-Dimethyl-1-(3-(4-nitrophenoxy)phenyl)ethanamine, (S)-;DTXSID801177965;Benzenemethanamine, N,N,I+/--trimethyl-3-(4-nitrophenoxy)-, (I+/-S)-;(aS)-N,N,a-Trimethyl-3-(4-nitrophenoxy)benzenemethanamine;RIVASTIGMINE TARTRATE IMPURITY, ETHER IMPURITY- [USP IMPURITY];

IGNXGHWUJLKYJA-LBPRGKRZSA-N

1S/C16H18N2O3/c1-12(17(2)3)13-5-4-6-16(11-13)21-15-9-7-14(8-10-15)18(19)20/h4-12H,1-3H3/t12-/m0/s1

O(C1C=CC(=CC=1)[N+](=O)[O-])C1=CC=CC(=C1)[C@H](C)N(C)C